Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery.

Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, Shieh CY, Morehead-Gee A, Gerber LH, Stout NL.

Breast Cancer Res Treat. 2012 Jul;134(1):315-24. doi: 10.1007/s10549-012-2061-1. Epub 2012 Apr 19.

PMID:
22527107
2.

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

Fern√°ndez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen C, Di Prospero NA, Fischbeck KH.

Lancet Neurol. 2011 Feb;10(2):140-7. doi: 10.1016/S1474-4422(10)70321-5. Epub 2011 Jan 6.

3.

Clinical features of spinal and bulbar muscular atrophy.

Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, Lehky TJ, Shrader JA, Levy EW, Harris-Love M, Di Prospero NA, Fischbeck KH.

Brain. 2009 Dec;132(Pt 12):3242-51. doi: 10.1093/brain/awp258.

4.

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.

Dalakas MC, Rakocevic G, Schmidt J, Salajegheh M, McElroy B, Harris-Love MO, Shrader JA, Levy EW, Dambrosia J, Kampen RL, Bruno DA, Kirk AD.

Brain. 2009 Jun;132(Pt 6):1536-44. doi: 10.1093/brain/awp104. Epub 2009 May 19.

Supplemental Content

Loading ...
Support Center